<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although elevated expression of CAV1/caveolin 1 is associated with the malignant progression of various human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, the molecular mechanism underlying its oncogenic functions is largely unknown </plain></SENT>
<SENT sid="1" pm="."><plain>We found that CAV1 is frequently overexpressed in advanced <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> due to aberrant promoter CpG site hypomethylation, and its elevation is implicated in enhanced aerobic glycolysis of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_63'>Depletion</z:mpath> of elevated CAV1 downregulates <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake, intracellular ATP level and <z:chebi fb="4" ids="24996">lactate</z:chebi> accumulation, and triggers autophagy through activation of AMPK-TP53/p53 signaling </plain></SENT>
<SENT sid="3" pm="."><plain>CAV1 elevation increases <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake and ATP production by stimulating transcription of the <z:chebi fb="105" ids="17234">glucose</z:chebi> transporter SLC2A3/GLUT3 via an HMGA1-binding site within the promoter </plain></SENT>
<SENT sid="4" pm="."><plain>Collectively, our study suggests that elevated CAV1 expression may contribute to <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> progression by providing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells growth and survival advantages under nutritional stress conditions </plain></SENT>
</text></document>